Pioneering Progress
Across Sectors for a Better Tomorrow.
The IRM Group is a diverse ecosystem of enterprises— united by the purpose of touching lives through innovation. Its foundation was laid by Shri I.A. Modi, a visionary nationalist who established Cadila Pharmaceuticals, guided by his deep commitment to universal wellness
IRM Group Co. was established in 1987, with the objective of absorbing all non- pharma businesses of Cadila pharmaceuticals. CPL Vetnova (established in 1972) is the oldest business to become part of IRM group, followed by Karnavati engineering (established in 1981), CADAgro (established in 1992), FMS (established in 1994) and most recently, Rousdonmullai Tea Estate (established in 2005).
Fondly known as the Medicine Man of India, founded Cadila Pharmaceuticals with a mission to make quality, affordable medicines accessible to all. His journey was guided by 3 core values of Authenticity, Responsibility and Integrity. Shri Modi believed in self-reliance and ethical business, handling R&D, production, marketing, and delivery personally in the early days of the company.
His principle: “Your customers are the kings. Never cheat them!”, still drives all group companies purpose.
A firm believer in ethical practices, he ensured that the company always upheld legal and regulatory standards. He fostered a culture of ownership within the organisation, encouraging his team to lead with responsibility and customer focus. Under his leadership, Cadila evolved into a diversified group with a strong presence across pharmaceuticals, agriculture, and engineering. His values of authenticity, responsibility and integrity continue to guide every arm of the IRM Group.
A scientist at heart and a strategist by vision, Dr. Rajiv I. Modi took over the leadership in 2012, ushering in a new era of global growth and scientific advancement. His approach blends scientific curiosity with sharp business acumen, strengthening Cadila Group’s innovation pipeline and modernizing its operations. He has been instrumental in elevating the role of biotechnology within the organization, placing research and development at the forefront of group’s progress. Dr Modi earned his Ph.D. in Biological Sciences from the University of Michigan, holds a Master's degree from University College London, and a Bachelor’s degree in Chemical Engineering from IIT Bombay. He continues to steer the company with a future-focused mindset—committed to scientific integrity, global excellence, and transformative impact across healthcare and allied sectors
Mr. Rajiv R. Modi is an accomplished entrepreneur and strategic thinker with crosssector experience in hospitality, aviation, energy, and pharmaceuticals. Appointed as an Independent Director at Cadila Group in 2024, he brings a fresh perspective shaped by innovation and global exposure. With a strong academic foundation in Cambridge Advanced Level and IGCSE, he blends analytical rigor with practical leadership. Beyond business, Mr. Modi is passionate about social impact—actively promoting green initiatives, public health awareness, and international collaboration. His commitment to excellence, ethical governance, and sustainable development continues to guide his contributions to the Board and the broader Cadila vision.
An Engineer with a PG Diploma in Management, an astute professional with 43 years of diverse experience in Strategic Planning , Marketing , Sales , Service , New Business Development , HR , Project Engineering , Mass Media.. His grooming was done by St. Xavier’s School & College Ahmedabad and MSU of Baroda , and development aided by IIM Ahmedabad and Hitachi Institute of Management Development , Tokyo. He is a Non Executive Director at IRM Energy Ltd , an Independent Director at Shah Investor’s Home Ltd. and the Chairman at Ahmedabad District Branch of the Indian Red Cross Society.
Priya Gopesh, a B.Com graduate, CA and CWA, brings 24 years of rich experience in finance and compliance. She has been an integral part of the IRM and Cadila family. Her sharp acumen and unwavering commitment continues to drive financial excellence and support IRM’s sustained growth.